Kevin Weil launches Warp Sciences, aiming to speed medicine development with AI and robotics

Kevin Weil introduced Warp Sciences as a company aiming to use AI and robotics to help develop medicines faster. He says it raised a $215 million Series A led by Lightspeed and wants to bring frontier AI into the lab. Weil named three co-founders, while TradedVC listed three additional investment firms. Weil’s announcement describes goals, not demonstrated gains in medicine development.